Skip to main content
NVDA-0.16%AAPL+0.15%GOOGL+1.55%MSFT+0.91%AMZN+0.48%TSM+2.41%SPCX-0.56%META-0.65%AVGO+1.41%TSLA+0.75%SKHY+0.73%MU-0.89%LLY+1.00%BRK-B-1.52%AMD+9.95%JPM+0.68%WMT+0.67%V+0.45%XOM-3.14%ASMLa+0.44%JNJ-0.19%INTC+12.14%0700.HK+5.02%MA+0.43%ABBV+0.22%1398.HK-0.53%CSCO+1.78%ORCL+0.65%BAC+0.40%CVX-2.73%COST+0.35%DELL+1.26%LRCX+4.92%CAT+0.93%KO-1.28%AMAT+4.42%AP2d-0.08%0005.HK-1.36%HSBA.L-0.23%PG-0.19%ARM+17.16%UNH+0.18%GE+1.51%3988.HK-0.66%MS+1.75%1816.HK-0.71%NFLX+2.19%0939.HK-0.20%0857.HK-0.84%HD-0.93%CADCHF-0.70%GBPCHF-0.60%USDTHB-0.56%NZDCAD+0.54%EURCHF-0.54%CHFJPY+0.53%AUDCHF-0.49%GBPNZD-0.45%NZDMXN+0.44%EURNZD-0.43%GBPTRY+0.41%USDCAD+0.37%NZDJPY+0.37%USDCHF-0.34%AUDNZD-0.34%GBPHKD+0.32%EURSEK-0.31%GBPMXN-0.28%USDSEK-0.28%GBPUSD-0.27%AUDNOK-0.23%EURUSD-0.22%PLNJPY-0.22%AUDSGD-0.20%NZDSGD+0.20%AUDCAD+0.20%CADJPY-0.20%GBPSGD-0.19%USDJPY+0.17%NZDUSD+0.17%GBPZAR-0.17%USDILS+0.16%EURNOK-0.16%AUDUSD-0.16%USDMXN+0.14%EURSGD-0.14%NZDCHF-0.14%USDNOK-0.13%EURCAD+0.12%USDTRY+0.11%EURZAR-0.11%GBPAUD-0.11%USDSGD-0.11%CHFSGD+0.11%GBPCAD+0.10%GBPJPY-0.10%EURCZK+0.09%CHFNOK+0.09%USDZAR-0.08%EURCNH+0.07%USDPLN+0.07%CHFSEK-0.07%EURGBP+0.07%AUDDKK-0.06%EURHKD-0.06%EURJPY-0.05%SGDJPY-0.05%EURPLN+0.04%EURAUD-0.04%USDCNH+0.04%USDCOP-0.04%USDDKK+0.03%USDHKD-0.03%NOKJPY-0.02%AUDJPY+0.01%EURDKK0.00%USOIL-2.06%UKOIL-1.66%W1-1.21%COCOA-1.21%COTTON-1.16%GAGUSD-0.89%XAGUSD-0.89%XNGUSD+0.89%HG1+0.87%SUGAR-0.83%C1-0.67%GAUUSD-0.64%BTCUSD-0.67%ETHUSD+0.62%USDTUSD-0.06%XRPUSD+1.28%SOLUSD-1.51%TRXUSDT+0.46%ZECUSDT+3.25%DOGEUSD-1.74%XMRUSDT+0.15%LINKUSD-0.23%XLMUSD-2.37%UNIUSD-2.85%BCHUSDT+1.39%LTCUSD-2.73%HBARUSDT+0.87%SUIUSD+1.74%TONUSD+18.31%TAOUSDT+0.98%AAVEUSD-3.28%DOTUSDT-1.58%ICPUSDT+0.38%ONDOUSDT-1.70%ARBUSDT-1.86%WLDUSDT-1.08%JUPUSDT-1.52%ATOMUSDT-3.18%INJUSDT+3.11%STXUSDT+1.49%FETUSDT+3.90%SEIUSDT+1.94%TIAUSDT+0.41%PYTHUSDT-2.38%IMXUSDT-0.80%WIFUSDT+4.20%GRTUSDT+0.96%OPUSDT-1.99%POLUSDT-3.63%FARTCOINUSDT-1.29%IOTAUSDT-1.57%AXSUSDT-2.30%EOSUSDT-0.32%DYDXUSDT+0.60%ORDIUSDT-1.67%GALAUSDT-2.05%NOTUSDT-2.28%RONINUSDT-2.37%NVDA-0.16%AAPL+0.15%GOOGL+1.55%MSFT+0.91%AMZN+0.48%TSM+2.41%SPCX-0.56%META-0.65%AVGO+1.41%TSLA+0.75%SKHY+0.73%MU-0.89%LLY+1.00%BRK-B-1.52%AMD+9.95%JPM+0.68%WMT+0.67%V+0.45%XOM-3.14%ASMLa+0.44%JNJ-0.19%INTC+12.14%0700.HK+5.02%MA+0.43%ABBV+0.22%1398.HK-0.53%CSCO+1.78%ORCL+0.65%BAC+0.40%CVX-2.73%COST+0.35%DELL+1.26%LRCX+4.92%CAT+0.93%KO-1.28%AMAT+4.42%AP2d-0.08%0005.HK-1.36%HSBA.L-0.23%PG-0.19%ARM+17.16%UNH+0.18%GE+1.51%3988.HK-0.66%MS+1.75%1816.HK-0.71%NFLX+2.19%0939.HK-0.20%0857.HK-0.84%HD-0.93%CADCHF-0.70%GBPCHF-0.60%USDTHB-0.56%NZDCAD+0.54%EURCHF-0.54%CHFJPY+0.53%AUDCHF-0.49%GBPNZD-0.45%NZDMXN+0.44%EURNZD-0.43%GBPTRY+0.41%USDCAD+0.37%NZDJPY+0.37%USDCHF-0.34%AUDNZD-0.34%GBPHKD+0.32%EURSEK-0.31%GBPMXN-0.28%USDSEK-0.28%GBPUSD-0.27%AUDNOK-0.23%EURUSD-0.22%PLNJPY-0.22%AUDSGD-0.20%NZDSGD+0.20%AUDCAD+0.20%CADJPY-0.20%GBPSGD-0.19%USDJPY+0.17%NZDUSD+0.17%GBPZAR-0.17%USDILS+0.16%EURNOK-0.16%AUDUSD-0.16%USDMXN+0.14%EURSGD-0.14%NZDCHF-0.14%USDNOK-0.13%EURCAD+0.12%USDTRY+0.11%EURZAR-0.11%GBPAUD-0.11%USDSGD-0.11%CHFSGD+0.11%GBPCAD+0.10%GBPJPY-0.10%EURCZK+0.09%CHFNOK+0.09%USDZAR-0.08%EURCNH+0.07%USDPLN+0.07%CHFSEK-0.07%EURGBP+0.07%AUDDKK-0.06%EURHKD-0.06%EURJPY-0.05%SGDJPY-0.05%EURPLN+0.04%EURAUD-0.04%USDCNH+0.04%USDCOP-0.04%USDDKK+0.03%USDHKD-0.03%NOKJPY-0.02%AUDJPY+0.01%EURDKK0.00%USOIL-2.06%UKOIL-1.66%W1-1.21%COCOA-1.21%COTTON-1.16%GAGUSD-0.89%XAGUSD-0.89%XNGUSD+0.89%HG1+0.87%SUGAR-0.83%C1-0.67%GAUUSD-0.64%BTCUSD-0.67%ETHUSD+0.62%USDTUSD-0.06%XRPUSD+1.28%SOLUSD-1.51%TRXUSDT+0.46%ZECUSDT+3.25%DOGEUSD-1.74%XMRUSDT+0.15%LINKUSD-0.23%XLMUSD-2.37%UNIUSD-2.85%BCHUSDT+1.39%LTCUSD-2.73%HBARUSDT+0.87%SUIUSD+1.74%TONUSD+18.31%TAOUSDT+0.98%AAVEUSD-3.28%DOTUSDT-1.58%ICPUSDT+0.38%ONDOUSDT-1.70%ARBUSDT-1.86%WLDUSDT-1.08%JUPUSDT-1.52%ATOMUSDT-3.18%INJUSDT+3.11%STXUSDT+1.49%FETUSDT+3.90%SEIUSDT+1.94%TIAUSDT+0.41%PYTHUSDT-2.38%IMXUSDT-0.80%WIFUSDT+4.20%GRTUSDT+0.96%OPUSDT-1.99%POLUSDT-3.63%FARTCOINUSDT-1.29%IOTAUSDT-1.57%AXSUSDT-2.30%EOSUSDT-0.32%DYDXUSDT+0.60%ORDIUSDT-1.67%GALAUSDT-2.05%NOTUSDT-2.28%RONINUSDT-2.37%
VE

Vericel Corporation (VCEL)

NASDAQ • Healthcare

$39.54
-$0.47 (-1.2%)
Market closed

Last close at September 21, 2026 at 20:00 UTC

Open$39.22
Day Range$39.14 - $39.7
Avg. Volume (3M)518.7K
Market Cap$2B
P/E Ratio82.4
52 Week Range
$28.95$49.32
Next EarningsIn 44 daysNov 5, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$77.4M100%
Gross Profitminus cost of goods$56.4M73%
Operating Incomeminus R&D and overhead$434K1%
Net Incomeminus taxes and the rest$2.2M3%

In plain terms: out of every $100 in revenue, Vericel Corporation keeps $3 as net profit.

Fundamentals & Financials

Revenue (TTM)
$306.3M
Net Income (TTM)
$24.2M
EPS (TTM)
$0.48
ROA (TTM)
4.82%
Current Ratio
5.04

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

0.0%Q1 2026$0.45
+20.0%Q2 2026-$0.12
+238.2%Q3 2026$0.04
Next

Nov 5

in 44 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +238.2%

Vericel’s revenue topped consensus and rose year over year in the second fiscal quarter of 2026, reported July 30, 2026, with revenue of $77.5 million against a $72.7 million estimate, +6.5%, and up 22.5% from roughly $63.2 million a year ago. Profitability remained concentrated in gross profit, which came in at about $56.4 million with gross margin near 73%, while operating income was roughly $0.4 million for an operating margin of about 0.6%. Net income was about $2.2 million, improving from roughly negative $0.6 million a year ago, and EPS was $0.04 versus $-0.01 in the prior-year period. The company generated operating cash flow of about $16.2 million. For the next period, consensus calls for EPS of $0.02 on revenue of $78.0 million.

View full earnings history

About Vericel Corporation

Vericel Corporation is a NASDAQ-listed healthcare company focused on biotechnology-based cell therapies. It researches, develops, produces, and distributes treatments for sports medicine and critical burn care in the United States, where it generated $276.3 million of revenue in FY2025 from its marketed burn-care and cartilage-repair portfolio.

Name
Vericel Corporation
CEO
Dominick C. Colangelo
Website
vcel.com
Industry
Healthcare
Year Founded
1989
Employees
398

Today's Snapshot

AI-generated

VCEL closed 1.2% lower at 39.55, against a firmer sector.

Trading Volume

Below 10d avg (546.0K)

402.1K

vs S&P 500 Today

Underperforming Market

-2.78%

Updated: September 21, 2026 at 21:07 UTC

Technical Indicators

1 Buy3 Neutral4 Sell
VCEL at about 39.55 registers as a sell signal largely because the stock is trading beneath most medium-term averages even though it remains above the 200-day line, creating a mixed but bearish bias. Momentum is slightly negative and MACD is non-supportive, while RSI and other oscillators sit around neutral, so there is little bullish conviction. ADX indicates only modest trend strength and ATR points to moderate volatility, while on-balance volume does not confirm buying interest and the pivot sits above the market as resistance. Technical takeaway: Sell — price below key short-to-mid averages with weak volume confirms the bias.
All signals
  • EMA (5 indicators)$38.93 - $41.56
    Sell
  • RSI (14)40.44
    Neutral
  • Stochastic %K (14, 3, 3)60.79
    Neutral
  • MACD Level (12, 26)-0.99
    Neutral

Peers & Related Assets

EWTXEdgewise Therapeutics, Inc.
$44.64-1.5%
VRDNViridian Therapeutics, Inc.
$21.58-1.9%
HRMYHarmony Biosciences Holdings, Inc.
$42.1+0.2%
OCULOcular Therapeutix, Inc.
$9.990.0%
AUPHAurinia Pharmaceuticals Inc.
$16.61-1.7%
NUVBNuvation Bio Inc.
$6.07+3.8%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.